title: Discrepancies in fluoroquinolone clinical categories between the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI for Escherichia coli harbouring qnr genes and mutations in gyrA and parC.
authors.forename: Jose M
authors.initials: JM
authors.lastname: Rodríguez-Martínez
authors.forename: Alejandra
authors.initials: A
authors.lastname: Briales
authors.forename: Carmen
authors.initials: C
authors.lastname: Velasco
authors.forename: Paula
authors.initials: P
authors.lastname: Díaz de Alba
authors.forename: Luis
authors.initials: L
authors.lastname: Martínez-Martínez
authors.forename: Alvaro
authors.initials: A
authors.lastname: Pascual
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D027081:DNA Gyrase / Q000235:genetics*; D027101:DNA Topoisomerase IV / Q000235:genetics*; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli / Q000187:drug effects* / Q000235:genetics; D029968:Escherichia coli Proteins / Q000235:genetics*; D024841:Fluoroquinolones / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods / Q000592:standards; D009154:Mutation
chemical_list: D000900:Anti-Bacterial Agents; D029968:Escherichia coli Proteins; D024841:Fluoroquinolones; C485384:Qnr protein, E coli; D027101:DNA Topoisomerase IV; D027081:DNA Gyrase